Goldman Sachs has released a 2026 board governance outlook built around three pressure points: artificial intelligence oversight, shareholder activism, and Delaware corporate law.

The Goldman Sachs Research piece, titled "Board Governance in 2026: AI Oversight, Activism, and Delaware's Edge," treats the three themes as a connected governance stack. Directors who handle one poorly, the analysis argues, create openings in the others.

Why are AI, activism, and Delaware bundled together?

Boards entered the current cycle carrying a heavier governance load than at any point in the past decade. AI moved from experimentation to deployment across financial services, healthcare, and manufacturing.

Activist campaigns continued to target companies with governance gaps and capital-allocation questions. The Delaware Court of Chancery kept refining fiduciary duty, disclosure, and controller-transaction doctrine in ways other states often follow.

Goldman Sachs's outlook consolidates these pressures into a single 2026 checklist.

What does AI oversight demand of boards in 2026?

The artificial intelligence section addresses how directors should organize oversight as AI moves into revenue systems, customer-facing products, and internal decisioning. The report frames committee charters, director expertise, and risk-disclosure frameworks as the practical decision points.

For most large-cap boards, AI oversight is no longer a question of whether to engage. Companies have responded by adding technology committees, recruiting directors with AI backgrounds, and folding AI risk into existing audit and risk-committee charters.

Goldman Sachs treats these moves as starting points rather than end states. Boards face deeper questions about how to evaluate AI risks, disclose AI use to investors, and balance innovation with fiduciary duty.

How are activists likely to approach 2026 proxy contests?

The activism pillar examines how activists will press companies through board challenges, capital-allocation campaigns, and ESG-related proposals. Goldman Sachs treats activism as a continuing feature of public-company governance rather than an episodic disruption.

The implications run through director recruitment, board refreshment policies, and shareholder engagement budgets. Companies facing potential campaigns must decide whether to engage preemptively, defend publicly, or seek settlements that often include board seats.

The outlook expects 2026 activists to combine traditional governance critiques with newer themes: AI deployment, climate commitments, and workforce policies. Boards with documented oversight gaps may face heightened vulnerability.

Why does Delaware's doctrine matter outside Delaware?

The Delaware component focuses on the Court of Chancery and the state's continuing influence on fiduciary duty doctrine. The "edge" framing points to Delaware's role as the incorporation state for most large US public companies and the tendency of other jurisdictions to follow Chancery rulings.

Directors operating under Delaware law face a moving target. The court continues to refine standards on disclosure, controller transactions, and duty-of-care claims.

Delaware decisions shape what activists and plaintiffs can demand. They also define what directors must defend in M&A, going-private transactions, and derivative suits.

Goldman Sachs treats Delaware doctrine as the connective tissue between AI oversight and activism. A board that struggles with AI disclosure, for example, faces a Delaware court increasingly willing to evaluate director process. Activists can then use those disclosure gaps as leverage.

What does the outlook ask directors to do differently?

Goldman Sachs's coverage combines legal analysis with capital-markets perspective, treating the three themes as interconnected. The implicit message: a board that ignores AI oversight may find itself vulnerable to activists who frame governance gaps as value destruction, while Delaware rulings increasingly inform what activists can demand.

Boards preparing for the same cycle should expect the three themes to converge in proxy fights, M&A negotiations, and derivative suits throughout 2026.